NPPES file of Aug 9, 2026

Philip R. Orlander, M.D.

Endocrinology, Diabetes & Metabolism Physician · Houston, TX

Philip R. Orlander, M.D. is an endocrinology, diabetes & metabolism physician with a practice address in Houston, Texas, and NPI 1356369615, issued on Jul 17, 2006. Check the license (Texas G4668, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1356369615
Name
Philip R. Orlander
Credential
M.D.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
G4668 TX
Self-reported in NPPES; status is on the state search
Practice location
6410 Fannin St, Houston, TX 77030
Phone
(832) 325-7161
Enumerated
Jul 17, 2006
Record last updated
Feb 11, 2008 (not updated in 18 years: call before relying on the address or phone)
Fax
(713) 500-6497
Medicare enrollment
Enrolled (PECOS I20100106000079); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 6410 Fannin St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Mohammad AbdulmonemPediatric Endocrinology Physician1356226161
  2. Katelyn AbelStudent in an Organized Health Care Education/Training Program1063350106
  3. Yewande Adesanya, ACNPAcute Care Nurse Practitioner1922374974
  4. Olasunkanmi Adeyinka, M.D.Family Medicine Physician1013948181
  5. Roukaya Al Hammoud, MDPediatric Infectious Diseases Physician1619107190
  6. Rami Aladham, M.D.Student in an Organized Health Care Education/Training Program1457739260

Verify Philip R. Orlander in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license G4668
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

9% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

2,876 Medicare Part D claims for 224 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims.

  1. Philip Orlander2,876
  2. Specialty average2,630

Most prescribed

  1. Levothyroxine Sodium234 claims
  2. Metformin Hcl Er158 claims
  3. Mounjaro138 claims
  4. Ozempic132 claims
  5. Synthroid128 claims
  6. Jardiance126 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 82.4 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score79.2
  2. Costout of 100 · 30%58.5
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $15.16

1 payment: food and beverage; the largest payer was Beta Bionics, Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Philip Orlander$15.16
  2. Specialty average$5,742.15

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. UT PhysiciansHouston, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Philip R. Orlander among 743 endocrinology, diabetes & metabolism physician records in Texas

Philip R. Orlander, M.D. is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 6% of them.

  • NPI issued2006 · 6% of these records are older, 61% newer
  • In a Medicare fileYes · 87% of these records are
  • In the CMS Doctors and Clinicians fileYes · 75% of these records are
  • Graduated1976 · median 2004 among the 560 with a school on file
  • Record last updated2008 · 50% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Texas

There are 743 endocrinology, diabetes & metabolism physician records in Texas.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Mandeep Bajaj, M.D.Houston, TX 770301376559971
  2. Cristina Boccalandro, M.D.Houston, TX 770301508890427
  3. Mouhammed Habra, M.D.Houston, TX 770301548219413
  4. Carlos Hamilton, MDHouston, TX 770301326041567
  5. Dale Hamilton, MDHouston, TX 770301982669875
  6. Victor Lavis, M.D.Houston, TX 770301528014206
  7. Marco Marcelli, MDHouston, TX 770301710994074
  8. Yomna Monla, M.D.Houston, TX 770301376585851

Common questions

What is Philip R. Orlander, M.D.'s NPI number?

Philip R. Orlander, M.D.'s National Provider Identifier (NPI) is 1356369615, issued on Jul 17, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Philip R. Orlander, M.D. located?

The NPPES record lists a practice address at 6410 Fannin St, Houston, TX, 77030. Phone: (832) 325-7161. Providers update this record themselves, so call before visiting.

How can I verify Philip R. Orlander, M.D.'s license?

NPPES lists Texas license number G4668, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Philip R. Orlander, M.D. prescribe under Medicare Part D?

In 2024, Philip R. Orlander, M.D. had 2,876 Medicare Part D claims for 224 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Philip R. Orlander, M.D.'s MIPS final score?

The 2023 MIPS final score is 82.4 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.